PHARMACOTHERAPY OF BRONCHIAL ASTHMA: CURRENT STATUS AND PROSPECTS FOR DEVELOPMENT


DOI: https://dx.doi.org/10.18565/pharmateca.2018.8.58-64

A.V. Emelyanov, G.R. Sergeeva, E.V. Leshenkova, M.S. Partavi

Department of Pulmonology, North-Western State Medical University n.a. I.I. Mechnikov, Saint-Petersburg, Russia
The article discusses modern ideas about the treatment of bronchial asthma, one of the most widespread and socially significant diseases in the world. The issues of treatment of the disease at various stages of therapy and long-term management of patients are considered. The main groups of drugs recommended at present for the management of patients with bronchial asthma with its stable course are presented. The near-term prospects of improving the pharmacotherapy of this disease are discussed.
Keywords: bronchial asthma, treatment, control, stepwise therapy, new drugs

About the Autors


Corresponding author: A.V. Emelyanov – MD, Prof., Head of the Department of Pulmonology, NWSMU n.a. I.I. Mechnikov, St. Petersburg, Russia; tel. +7 (812) 970-71-88, e-mail: aleksandr.emelyanov@szgmu.ru


Бионика Медиа